drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   

Week of Mon, Mar 31st, 2014

Wheat Thins introduces popped chip snack

Mondelez International is expanding its better-for-you snack lineup with Wheat Thins Popped, the cracker brand's first popped chip.

Sunscreen Bands monitor sun exposure

JADS International LLC has rolled out its Sunscreen Bands sun safety wristbands to retail stores.

Zim's extends product roster with Zim's Advanced

Perfecta Products Inc. has expanded its Zim's brand with the Zim's Advanced line.

Parata e-learning series highlights growing role of pharmacists

Parata Systems has launched an e-learning series that targets pharmacists and focuses on the profession's expanding health care role.

Prasco rolls out Evista authorized generic

Prasco Laboratories has signed a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Evista tablets (raloxifene hydrochloride 60 mg) in the United States.

Perrigo ships authorized generic of Taclonex

Perrigo Co. plc has released calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment, a treatment for psoriasis.

Greenstone launches Feldene authorized generic

Greenstone LLC has expanded its lineup of generic pharmaceuticals with the release of piroxicam capsules, an anti-inflammatory drug.

Mederma adds nighttime product to scar care line

Merz North America has launched Mederma PM Intensive Overnight Scar Cream, which the company called the first nighttime scar care product.

Finger injury kit hits shelves at Boots stores

Health Enterprises Inc. has landed retail distribution for its Acu-Life 3-in-1 Finger Injury Kit at Boots stores.

Rising Pharmaceuticals to acquire PACK Pharmaceuticals

Rising Pharmaceuticals plans to buy PACK Pharmaceuticals, a national marketer and distributor of generic and over-the-counter drugs, in a deal valued at $100 milion.

Janssen's Topamax OK'd as migraine treatment for adolescents

The Food and Drug Administration has approved Janssen Pharmaceuticals Inc.'s Topamax for the prevention of migraine headaches in adolescents ages 12 to 17.